Mature T‐cell leukemia/lymphoma with an NK ‐like immunophenotype: A report of 7 cases
Cytometry Part B: Clinical Cytometry · 2026
DOI: 10.1002/cyto.b.70020 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cytometry Part B: Clinical Cytometry, 2026. Verfasst von Wei J Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Killer Cells, Natural, Lymphoma, T-Cell. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Distinguishing T‐cell from NK‐cell neoplasms can occasionally be challenging, as neoplastic T cells can lose T‐cell markers such as surface CD3 (sCD3) and CD5 while acquiring NK‐cell markers such as CD16, CD56, and CD94. In this study, we present a series of 7 mature T‐cell lymphoma/leukemia cases with NK‐like immunophenotypes to clarify diagnostic approaches for lineage determination. The cohort included 3 cases of peripheral T‐cell lymphoma, not otherwise specified, 2 cases of T‐large granular lymphocytic leukemia, and 2 cases of hepatosplenic T‐cell lymphoma. In all cases, flow cytometry immunophenotypic analysis showed that the neoplastic cells exhibited an NK‐like immunophenotype characterized by expression of CD56 and CD94 in all 7 cases, with 4 cases also positive for CD16. Concurrently, the neoplastic cells in all cases were negative for the T‐cell markers, including sCD3, CD4, CD5, TCRαβ, TCRγδ, and TRBC1 by flow cytometry. These immunophenotypic features mimicked NK cells. But in T‐cell receptor ( TCR ) gene rearrangement analysis, all 7 cases had monoclonal TRG rearrangements, and 4 cases also showed concurrent TRB rearrangements. Immunohistochemical analysis showed that all 6 tested cases were positive for BCL11B, and 1 case was positive for TCRαβ. Additionally, 2 of 3 cases assessed using a T‐cell‐specific CD3 antibody were positive for cytoplasmic CD3 by flow cytometry. In summary, this study illustrates that neoplastic T cells can show an NK‐like immunophenotype. Features useful for supporting T‐lineage in this context include cytoplasmic CD3 expression assessed using a T‐cell‐specific CD3 antibody, clonal TCR gene rearrangement, BCL11B expression, and detection of TCRαβ, TCRγδ, or TRBC by immunohistochemistry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
ORCID-Profile: Wei J Wang, Sa A Wang, Hong Fang, Jeffrey L Jorgensen, Shimin Hu, Lianqun Qiu, Jie Xu, L Jeffrey Medeiros, Wei Wang
Zitieren
APA
Wang, W. J., Wang, S. A., Fang, H., Jorgensen, J. L., Hu, S., Qiu, L., Xu, J., Medeiros, L. J., & Wang, W. (2026). Mature T‐cell leukemia/lymphoma with an NK ‐like immunophenotype: A report of 7 cases. Cytometry Part B: Clinical Cytometry. https://doi.org/10.1002/cyto.b.70020
Vancouver
Wang WJ, Wang SA, Fang H, Jorgensen JL, Hu S, Qiu L, et al. Mature T‐cell leukemia/lymphoma with an NK ‐like immunophenotype: A report of 7 cases. Cytometry Part B: Clinical Cytometry. 2026. doi:10.1002/cyto.b.70020
BibTeX
@article{Wang2026,
author = {Wang, Wei J and Wang, Sa A and Fang, Hong and Jorgensen, Jeffrey L and Hu, Shimin and Qiu, Lianqun and Xu, Jie and Medeiros, L Jeffrey and Wang, Wei},
title = {Mature T‐cell leukemia/lymphoma with an NK ‐like immunophenotype: A report of 7 cases},
journal = {Cytometry Part B: Clinical Cytometry},
year = {2026},
doi = {10.1002/cyto.b.70020}
}
EUVIMED